{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T13:56:29Z","timestamp":1720706189690},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) \/ Bolsa Jovem Talento (BJT) - Programa Ci\u00eancias Sem Fronteiras","award":["301520\/2014-3"],"award-info":[{"award-number":["301520\/2014-3"]}]},{"name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro (FAPERJ)"},{"name":"Newton Fund RCUK-CONFAP Research Partnerships call, FAPERJ","award":["E-26\/170.021\/2015"],"award-info":[{"award-number":["E-26\/170.021\/2015"]}]},{"name":"Newton Fund RCUK-CONFAP Research Partnerships call, Medical Research Council (MRC)","award":["MR\/M026515\/1"],"award-info":[{"award-number":["MR\/M026515\/1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12879-017-2619-y","type":"journal-article","created":{"date-parts":[[2017,7,31]],"date-time":"2017-07-31T10:51:28Z","timestamp":1501498288000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Age-standardized mortality rates related to viral hepatitis in Brazil"],"prefix":"10.1186","volume":"17","author":[{"given":"Hugo","family":"Perazzo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio G","family":"Pacheco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula M","family":"Luz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodolfo","family":"Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Hyde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana","family":"Fittipaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Rigolon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra W","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Grinsztejn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valdil\u00e9a G","family":"Veloso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,31]]},"reference":[{"key":"2619_CR1","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","volume":"380","author":"R Lozano","year":"2012","unstructured":"Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380:2095\u2013128.","journal-title":"Lancet"},{"key":"2619_CR2","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S1665-2681(19)32086-1","volume":"4","author":"N Mendez-Sanchez","year":"2005","unstructured":"Mendez-Sanchez N, Villa AR, Chavez-Tapia NC, Ponciano-Rodriguez G, Almeda-Valdes P, Gonzalez D, Uribe M. Trends in liver disease prevalence in Mexico from 2005 to 2050 through mortality data. Ann Hepatol. 2005;4:52\u20135.","journal-title":"Ann Hepatol"},{"key":"2619_CR3","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.3748\/wjg.v22.i4.1570","volume":"22","author":"A Ferrarese","year":"2016","unstructured":"Ferrarese A, Zanetto A, Gambato M, Bortoluzzi I, Nadal E, Germani G, Senzolo M, Burra P, Russo FP. Liver transplantation for viral hepatitis in 2015. World J Gastroenterol. 2016;22:1570\u201381.","journal-title":"World J Gastroenterol"},{"key":"2619_CR4","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/QCO.0000000000000188","volume":"28","author":"R Aggarwal","year":"2015","unstructured":"Aggarwal R, Goel A. Hepatitis a: epidemiology in resource-poor countries. Curr Opin Infect Dis. 2015;28:488\u201396.","journal-title":"Curr Opin Infect Dis"},{"issue":"Suppl 1","key":"2619_CR5","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/liv.13014","volume":"36","author":"H Blasco-Perrin","year":"2016","unstructured":"Blasco-Perrin H, Abravanel F, Blasco-Baque V, Peron JM. Hepatitis E, the neglected one. Liver Int. 2016;36(Suppl 1):130\u20134.","journal-title":"Liver Int"},{"key":"2619_CR6","unstructured":"Brasil. Epidemiological Report of Viral Hepatitis [Boletim Epidemiol\u00f3gico de Hepatites Virais]. Bras\u00edlia, Brazil: Brazilian Ministry of Health [Ministerio da Saude do Brasil]; 2015."},{"key":"2619_CR7","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1186\/s12889-016-3784-4","volume":"16","author":"F Mesquita","year":"2016","unstructured":"Mesquita F, Santos ME, Benzaken A, Correa RG, Cattapan E, Sereno LS, Naveira MC. The Brazilian comprehensive response to hepatitis C: from strategic thinking to access to interferon-free therapy. BMC Public Health. 2016;16:1132.","journal-title":"BMC Public Health"},{"key":"2619_CR8","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.jhep.2014.05.041","volume":"61","author":"WS Braga","year":"2014","unstructured":"Braga WS, de Oliveira CM, de Araujo JR, Castilho Mda C, Rocha JM, Gimaque JB, Silva ML, Vasconcelos HL, Ramasawmy R, Parana R. Chronic HDV\/HBV co-infection: predictors of disease stage---a case series of HDV-3 patients. J Hepatol. 2014;61:1205\u201311.","journal-title":"J Hepatol"},{"key":"2619_CR9","doi-asserted-by":"crossref","first-page":"e0174453","DOI":"10.1371\/journal.pone.0174453","volume":"12","author":"I Couto","year":"2017","unstructured":"Couto I, Victoria M, Veloso VG, Rodrigues L, Grinsztejn B, Lacerda M, Victoria F, Perazzo H. Prevalence and predictors for compensated advanced chronic liver disease (c-ACLD) in patients with chronic Hepatitis Delta virus (HDV) infection. PLoS One. 2017;12:e0174453.","journal-title":"PLoS One"},{"key":"2619_CR10","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/liv.12470","volume":"34","author":"LA Nader","year":"2014","unstructured":"Nader LA, de Mattos AA, Bastos GA. Burden of liver disease in Brazil. Liver Int. 2014;34:844\u20139.","journal-title":"Liver Int"},{"key":"2619_CR11","doi-asserted-by":"crossref","unstructured":"Perazzo H, Pacheco AG, De Boni R, Luz P, Fittipaldi J, Cardoso S, Grinsztejn B, Veloso V. Age-standardized mortality rates related to cirrhosis in Brazil from 2000 to 2012: a nationwide analysis. Ann Hepatol. 2017(16):269\u201378.","DOI":"10.5604\/16652681.1231586"},{"key":"2619_CR12","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.bjid.2015.04.004","volume":"19","author":"PR Ferreira","year":"2015","unstructured":"Ferreira PR, Brandao-Mello CE, Estes C, Goncales Junior FL, Coelho HS, Razavi H, Cheinquer H, Wolff FH, Ferraz ML, Pessoa MG, et al. Disease burden of chronic hepatitis C in Brazil. Braz J Infect Dis. 2015;19:363\u20138.","journal-title":"Braz J Infect Dis"},{"key":"2619_CR13","unstructured":"Brasil. Guideline for information of cause of death in the death certificate [Manual de instru\u00e7\u00f5es para o preenchimento da declara\u00e7\u00e3o de obito]. Brasilia (DF): Brazilian Ministry of Health [Ministerio da Saude do Brasil]; 2001."},{"key":"2619_CR14","first-page":"10","volume":"7","author":"NN Naing","year":"2000","unstructured":"Naing NN. Easy way to learn standardization: direct and indirect methods. Malays J Med Sci. 2000;7:10\u20135.","journal-title":"Malays J Med Sci"},{"key":"2619_CR15","unstructured":"WHO World Population Standard (2000\u20132025). [ http:\/\/seer.cancer.gov\/stdpopulations\/world.who.html \/ stdpopulations \/world.who.html]."},{"key":"2619_CR16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1590\/S0074-02762006000200001","volume":"101","author":"CL Vitral","year":"2006","unstructured":"Vitral CL, Gaspar AM, Souto FJ. Epidemiological pattern and mortality rates for hepatitis a in Brazil, 1980-2002--a review. Mem Inst Oswaldo Cruz. 2006;101:119\u201327.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"2619_CR17","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1590\/S0037-86822005000400001","volume":"38","author":"MP Zago-Gomes","year":"2005","unstructured":"Zago-Gomes MP, Stantolin GC, Perazzio S, Aikawa KH, Goncalves CS, Pereira FE. Prevalence of anti-hepatits a antibodies in children of different socioeconomic conditions in Vila Velha, ES. Rev Soc Bras Med Trop. 2005;38:285\u20139.","journal-title":"Rev Soc Bras Med Trop"},{"key":"2619_CR18","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","volume":"386","author":"A Schweitzer","year":"2015","unstructured":"Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386:1546\u201355.","journal-title":"Lancet"},{"key":"2619_CR19","doi-asserted-by":"crossref","first-page":"808","DOI":"10.4269\/ajtmh.2005.73.808","volume":"73","author":"S Viana","year":"2005","unstructured":"Viana S, Parana R, Moreira RC, Compri AP, Macedo V. High prevalence of hepatitis B virus and hepatitis D virus in the western Brazilian Amazon. Am J Trop Med Hyg. 2005;73:808\u201314.","journal-title":"Am J Trop Med Hyg"},{"key":"2619_CR20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1590\/0037-8682-0176-2015","volume":"49","author":"FJ Souto","year":"2016","unstructured":"Souto FJ. Distribution of hepatitis B infection in Brazil: the epidemiological situation at the beginning of the 21 st century. Rev Soc Bras Med Trop. 2016;49:11\u201323.","journal-title":"Rev Soc Bras Med Trop"},{"key":"2619_CR21","doi-asserted-by":"crossref","first-page":"815","DOI":"10.5604\/16652681.1171756","volume":"14","author":"FP Pinto","year":"2015","unstructured":"Pinto FP, Ferreira OC Jr, Olmedo DB, Precioso PM, Barquette FR, Castilho MC, Silva SG, Porto LC. Prevalence of hepatitis B and C markers in a population of an urban university in Rio de Janeiro, Brazil: a cross-sectional study. Ann Hepatol. 2015;14:815\u201325.","journal-title":"Ann Hepatol"},{"key":"2619_CR22","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1471-2334-13-60","volume":"13","author":"LM Pereira","year":"2013","unstructured":"Pereira LM, Martelli CM, Moreira RC, Merchan-Hamman E, Stein AT, Cardoso MR, Figueiredo GM, Montarroyos UR, Braga C, Turchi MD, et al. Prevalence and risk factors of hepatitis C virus infection in Brazil, 2005 through 2009: a cross-sectional study. BMC Infect Dis. 2013;13:60.","journal-title":"BMC Infect Dis"},{"key":"2619_CR23","unstructured":"WHO Global hepatitis report 2017 [ http:\/\/www.who.int\/hepatitis\/publications\/global-hepatitis-report2017\/en\/ ]."},{"key":"2619_CR24","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(15)60692-4","volume":"386","author":"Global Burden of Disease Study 2013 Collaborators","year":"2015","unstructured":"Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2015;386:743\u2013800.","journal-title":"Lancet"},{"key":"2619_CR25","unstructured":"Institute for Health Metrics and Evaluation. Global Burden Disease Compare [ http:\/\/vizhub.healthdata.org\/gbd-compare ]."},{"key":"2619_CR26","doi-asserted-by":"crossref","first-page":"271","DOI":"10.7326\/0003-4819-156-4-201202210-00004","volume":"156","author":"KN Ly","year":"2012","unstructured":"Ly KN, Xing J, Klevens RM, Jiles RB, Ward JW, Holmberg SD. The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. Ann Intern Med. 2012;156:271\u20138.","journal-title":"Ann Intern Med"},{"key":"2619_CR27","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/jvh.12262","volume":"22","author":"ZM Younossi","year":"2015","unstructured":"Younossi ZM, Otgonsuren M, Henry L, Arsalla Z, Stepnaova M, Mishra A, Venkatesan C, Hunt S. Inpatient resource utilization, disease severity, mortality and insurance coverage for patients hospitalized for hepatitis C virus in the United States. J Viral Hepat. 2015;22:137\u201345.","journal-title":"J Viral Hepat"},{"key":"2619_CR28","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(14)61682-2","volume":"385","author":"GBD 2013 Mortality and Causes of Death Collaborators","year":"2015","unstructured":"GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-limita specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2015;385:117\u201371.","journal-title":"Lancet"},{"key":"2619_CR29","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1016\/S0140-6736(11)60055-X","volume":"377","author":"CG Victora","year":"2011","unstructured":"Victora CG. Barreto ML, do Carmo Leal M, Monteiro CA, Schmidt MI, Paim J, Bastos FI, Almeida C, Bahia L, Travassos C et al: health conditions and health-policy innovations in Brazil: the way forward. Lancet. 2011;377:2042\u201353.","journal-title":"Lancet"},{"key":"2619_CR30","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1590\/0037-8682-0230-2015","volume":"48","author":"JS Hanus","year":"2015","unstructured":"Hanus JS, Ceretta LB, Simoes PW, Tuon L. Incidence of hepatitis C in Brazil. Rev Soc Bras Med Trop. 2015;48:665\u201373.","journal-title":"Rev Soc Bras Med Trop"},{"key":"2619_CR31","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jcv.2008.12.008","volume":"44","author":"L Oliveira Mde","year":"2009","unstructured":"Oliveira Mde L, Bastos FI, Telles PR, Hacker Mde A, Oliveira SA, Miguel JC, Yoshida CF. Epidemiological and genetic analyses of hepatitis C virus transmission among young\/short- and long-term injecting drug users from Rio de Janeiro, Brazil. J Clin Virol. 2009;44:200\u20136.","journal-title":"J Clin Virol"},{"key":"2619_CR32","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1471-2334-14-94","volume":"14","author":"MA Crispim","year":"2014","unstructured":"Crispim MA, Fraiji NA, Campello SC, Schriefer NA, Stefani MM, Kiesslich D. Molecular epidemiology of hepatitis B and hepatitis delta viruses circulating in the western Amazon region. North Brazil BMC Infect Dis. 2014;14:94.","journal-title":"North Brazil BMC Infect Dis"},{"key":"2619_CR33","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1186\/s12879-015-1249-5","volume":"15","author":"HM Cruz","year":"2015","unstructured":"Cruz HM, Scalioni Lde P, de Paula VS, da Silva EF, do OK MFA, Cruz MS, Bastos FI, Pollo-Flores P, Leal E, et al. Evaluating HBsAg rapid test performance for different biological samples from low and high infection rate settings & populations. BMC Infect Dis. 2015;15:548.","journal-title":"BMC Infect Dis"},{"key":"2619_CR34","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1136\/jech-2011-200341","volume":"66","author":"RB Barata","year":"2012","unstructured":"Barata RB, Ribeiro MC, de Moraes JC, Flannery B. Socioeconomic inequalities and vaccination coverage: results of an immunisation coverage survey in 27 Brazilian capitals, 2007-2008. J Epidemiol Community Health. 2012;66:934\u201341.","journal-title":"J Epidemiol Community Health"},{"key":"2619_CR35","unstructured":"Brasil. Guideline for management and treatment of chronic hepatitis B and its co-infections [Protocolo Clinico e Diretrizes Terap\u00eauticas para Tratamento da Hepatite Viral Cr\u00f4nica B e co-infec\u00e7\u00f5es]. Brasilia (DF): Brazilian Ministry of Health [Ministerio da Saude do Brasil]; 2014."},{"key":"2619_CR36","doi-asserted-by":"crossref","first-page":"852968","DOI":"10.1155\/2015\/852968","volume":"2015","author":"R Castro","year":"2015","unstructured":"Castro R, Perazzo H, Grinsztejn B, Veloso VG, Hyde C. Chronic hepatitis C: an overview of evidence on epidemiology and management from a Brazilian perspective. Int J Hepatol. 2015;2015:852968.","journal-title":"Int J Hepatol"},{"key":"2619_CR37","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.12274","volume":"13","author":"L Rosa da","year":"2013","unstructured":"da Rosa L, Dantas-Correa EB, Narciso-Schiavon JL, Schiavon Lde L. Diagnostic performance of two point-of-care tests for anti-HCV detection. Hepat Mon. 2013;13:e12274.","journal-title":"Hepat Mon"},{"key":"2619_CR38","unstructured":"Brasil. The role of hepatic elastography on liver fibrosis staging [Elastografia hep\u00e1tica ultrass\u00f4nica no diagn\u00f3stico da fibrose hep\u00e1tica]. Brasilia (DF): Brazilian Ministry of Health [Ministerio da Saude do Brasil]; 2015."},{"key":"2619_CR39","unstructured":"Brasil. Guideline for management and treatment of chronic hepatitis C and its co-infections [Protocolo Clinico e Diretrizes Terap\u00eauticas para Tratamento da Hepatite Viral Cr\u00f4nica C e co-infec\u00e7\u00f5es]. Brasilia (DF): Brazilian Ministry of Health [Ministerio da Saude do Brasil]; 2015."},{"key":"2619_CR40","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1590\/0102-311X00131113","volume":"30","author":"EE Lima de","year":"2014","unstructured":"de Lima EE, Queiroz BL. Evolution of the deaths registry system in Brazil: associations with changes in the mortality profile, under-registration of death counts, and ill-defined causes of death. Cad Saude Publica. 2014;30:1721\u201330.","journal-title":"Cad Saude Publica"},{"key":"2619_CR41","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/ije\/dyn121","volume":"37","author":"E Franca","year":"2008","unstructured":"Franca E, de Abreu DX, Rao C, Lopez AD. Evaluation of cause-of-death statistics for Brazil, 2002-2004. Int J Epidemiol. 2008;37:891\u2013901.","journal-title":"Int J Epidemiol"},{"key":"2619_CR42","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1478-7954-9-39","volume":"9","author":"E Franca","year":"2011","unstructured":"Franca E, Campos D, Guimaraes MD, Souza Mde F. Use of verbal autopsy in a national health information system: effects of the investigation of ill-defined causes of death on proportional mortality due to injury in small municipalities in Brazil. Popul Health Metr. 2011;9:39.","journal-title":"Popul Health Metr"},{"key":"2619_CR43","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1590\/1415-790X201400010010ENG","volume":"17","author":"EB Franca","year":"2014","unstructured":"Franca EB, da Cunha CC, Vasconcelos AM, Escalante JJ, de Abreu DX, de Lima RB, de Morais Neto OL. Investigation of ill-defined causes of death: assessment of a program's performance in a state from the northeastern region of Brazil. Rev Bras Epidemiol. 2014;17:119\u201334.","journal-title":"Rev Bras Epidemiol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-017-2619-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T20:51:00Z","timestamp":1569963060000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-017-2619-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,31]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2619"],"URL":"https:\/\/doi.org\/10.1186\/s12879-017-2619-y","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,31]]},"article-number":"527"}}